⌘K
Loading ticker…
As of 2026-08-24, Merck & Co., Inc. (MRK) has a 3-month relative strength percentile of 84 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.7%, relative volume 1.42×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MRK is in a stage 2 uptrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 17.2% / 30.3%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
MRK appears in 1 ETF as of Jun 2026: PY at 1.98% weight, $4M notional.
Held by 438 ETFs · $51.3B across latest filings · largest weight 9.68% (PPH).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PY | 1.98% | $4M | +0.09 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MRK Jan avg: 2.92% median: 2.05% win: 50% σ: 6.20% n: 4 2022-04-12 → 2026-07-31 | MRK Feb avg: 2.46% median: 2.09% win: 50% σ: 8.17% n: 4 2022-04-12 → 2026-07-31 | MRK Mar avg: -0.41% median: -1.28% win: 50% σ: 3.11% n: 4 2022-04-12 → 2026-07-31 | MRK Apr avg: -1.09% median: -2.07% win: 40% σ: 6.85% n: 5 2022-04-12 → 2026-07-31 | MRK May avg: -0.91% median: -2.85% win: 40% σ: 7.25% n: 5 2022-04-12 → 2026-07-31 | MRK Jun avg: 2.69% median: 3.02% win: 60% σ: 4.00% n: 5 2022-04-12 → 2026-07-31 | MRK Jul avg: -3.64% median: -2.01% win: 20% σ: 4.27% n: 5 2022-04-12 → 2026-07-31 | MRK Aug avg: 2.53% median: 3.44% win: 75% σ: 5.17% n: 4 2022-04-12 → 2026-07-31 (current) | MRK Sep avg: -2.25% median: -2.18% win: 25% σ: 3.07% n: 4 2022-04-12 → 2026-07-31 | MRK Oct avg: 2.45% median: 1.10% win: 50% σ: 11.35% n: 4 2022-04-12 → 2026-07-31 | MRK Nov avg: 7.46% median: 4.30% win: 50% σ: 10.58% n: 4 2022-04-12 → 2026-07-31 | MRK Dec avg: 1.35% median: 0.58% win: 75% σ: 3.59% n: 4 2022-04-12 → 2026-07-31 |